HPR53 How Does the Inclusion of New Drugs in National Reimbursement Drug List Influence Health Outcomes and Financial Burden for Multiple Sclerosis Patients
Abstract
Authors
Y Jia H Li X Qiao H Gu M Hu
Y Jia H Li X Qiao H Gu M Hu
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now